Antiapoptotic function of 17AA(+)WT1 (Wilms' tumor gene) isoforms on the intrinsic apoptosis pathway

Oncogene
Ken ItoHaruo Sugiyama

Abstract

The WT1 gene is overexpressed in human primary leukemia and a wide variety of solid cancers. The WT1 gene is alternatively spliced at two sites, yielding four isoforms: 17AA(+)KTS(+), 17AA(+)KTS(-), 17AA(-)KTS(+), and 17AA(-)KTS(-). Here, we showed that 17AA(+)WT1-specific siRNA induced apoptosis in three WT1-expressing leukemia cell lines (K562, HL-60, and Kasumi-1), but not in WT1-non-expressing lymphoma cell line (Daudi). 17AA(+)WT1-specific siRNA activated caspase-3 and -9 in the intrinsic apoptosis pathway but not caspase-8 in the extrinsic one. On the other hand, 17AA(-)WT1-specific siRNA did not induce apoptosis in the three WT1-expressing cell lines. The apoptosis was associated with activation of proapoptotic Bax, which was activated upstream of the mitochondria. Constitutive expression of 17AA(+)WT1 isoforms inhibited apoptosis of K562 leukemia cells induced by apoptosis-inducing agents, etoposide and doxorubicin, through the protection of mitochondrial membrane damages, and DNA-binding zinc-finger region of 17AA(+)WT1 isoform was essential for the antiapoptotic functions. We further studied the gene(s) whose expression was altered by the expression of 17AA(+)WT1 isoforms and showed that the expression of proapoptotic...Continue Reading

References

Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·A L GashlerV P Sukhatme
Aug 27, 1993·Cell·J A KreidbergR Jaenisch
Feb 1, 1997·Transplantation Proceedings·K YamabeH Matsuda
May 1, 1997·Movement Disorders : Official Journal of the Movement Disorder Society·T HaniharaM Owada
Aug 7, 1997·International Journal of Cancer. Journal International Du Cancer·M OsakaT Sugiyama
Oct 23, 1997·American Journal of Medical Genetics·E TorbanP Goodyer
Apr 6, 1999·Japanese Journal of Cancer Research : Gann·Y OjiH Sugiyama
Sep 2, 1999·Current Biology : CB·U HerzerC Englert
May 25, 2001·International Journal of Hematology·H Sugiyama
Oct 17, 2001·Experimental Hematology·G HübingerU Maurer
Mar 13, 2002·The EMBO Journal·Kay-Dietrich WagnerHolger Scholz
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Yusuke OjiHaruo Sugiyama
Jun 26, 2003·Cancer Science·Takafumi UedaHaruo Sugiyama
Jul 5, 2003·Cancer Science·Yusuke OjiHaruo Sugiyama
Aug 7, 2003·Cancer Science·Yusuke OjiHaruo Sugiyama
Nov 7, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Y MiyoshiS Noguchi
Nov 13, 2003·British Journal of Cancer·J W LeeS H Lee
Jul 13, 2004·Cancer Science·Yusuke OjiHaruo Sugiyama
Oct 27, 2004·Cancer Science·Yusuke OjiHaruo Sugiyama
Apr 29, 2005·Journal of Applied Animal Welfare Science : JAAWS·John C NewPhilip H Kass
May 28, 2005·Leukemia·U KeilholzH Sugiyama

❮ Previous
Next ❯

Citations

Nov 12, 2013·Leukemia Research·Irene LunaMiguel A Sanz
Jan 31, 2013·Human Molecular Genetics·Giorgia MontanoPaola Costanzo
Apr 17, 2010·Japanese Journal of Clinical Oncology·Haruo Sugiyama
Sep 7, 2007·Pathology International·Takashi IwasakiTakashi Murate
Dec 3, 2011·Journal of Experimental & Clinical Cancer Research : CR·Shen-meng GaoFu-jun Yu
Nov 7, 2009·Pharmacogenomics·Christophe Roumier, Meyling H Cheok
Dec 26, 2006·Expert Review of Anticancer Therapy·Joseph G Sinkovics
Feb 14, 2014·Expert Opinion on Investigational Drugs·Lindsay A M Rein, Nelson J Chao
Dec 6, 2006·Drug Metabolism Reviews·Kenneth S RamosQiang He
Nov 25, 2014·Molecular Carcinogenesis·Yusuke OjiHaruo Sugiyama
Dec 30, 2015·Molecular Carcinogenesis·Nozomi HojoYusuke Oji
Apr 23, 2009·International Journal of Cancer. Journal International Du Cancer·Yusuke OjiHaruo Sugiyama
Apr 24, 2009·Journal of Animal Physiology and Animal Nutrition·Y-Q WangN E Forsberg
Jul 9, 2013·International Journal of Cancer. Journal International Du Cancer·Konstantina BourkoulaMin Li-Weber
Dec 17, 2009·Hematological Oncology·Carolyn OwenPeter Paschka
Jun 15, 2010·Cell Cycle·Jörg Hartkamp, Stefan G E Roberts
Feb 4, 2010·Molecular Cell·Jörg HartkampStefan G E Roberts
Aug 20, 2014·Frontiers in Physiology·Hitesh Batra, Veena B Antony
May 14, 2016·International Journal of Cancer. Journal International Du Cancer·Yusuke OjiHaruo Sugiyama
Sep 27, 2016·Journal of Oral Science·Ronell Bologna-MolinaToshinari Mikami
Jan 13, 2018·International Journal of Cancer. Journal International Du Cancer·Yusuke OjiHaruo Sugiyama
Mar 16, 2007·Leukemia·L YangM D Minden
Apr 14, 2007·Visual Neuroscience·Lawrence H PintoJoseph S Takahashi
Apr 1, 2008·European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society·Jan E Madsen, Gunnar Flugsrud
Jan 28, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Ling ChengKaren M Harnett
May 26, 2007·Expert Reviews in Molecular Medicine·Suzie Ariyaratana, David M Loeb
Feb 20, 2020·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Xiaonan H Wang, S Russ Price

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis